Identification and characterisation of novel bacteriocins active against Clostridioides difficile
Clostridioides difficile is a Gram-positive, spore forming, anaerobic bacilli which is a leading causative agent of antibiotic associated diarrhoea and represents a significant burden to medical systems worldwide. The current treatment for C. difficile is antibiotics, including vancomycin, which are...
| Main Author: | Chapman, Sarah May Olivia |
|---|---|
| Format: | Thesis (University of Nottingham only) |
| Language: | English |
| Published: |
2020
|
| Subjects: | |
| Online Access: | https://eprints.nottingham.ac.uk/60745/ |
Similar Items
Identification and characterisation of potential bacteriocins with biological activity against Clostridium difficile from environmental samples
by: Kim, Sungchan
Published: (2018)
by: Kim, Sungchan
Published: (2018)
Development of an oral vaccine against Clostridioides difficile
by: Karyal, Cansu
Published: (2021)
by: Karyal, Cansu
Published: (2021)
Developing a protein subunit oral vaccine against Clostridioides difficile
by: Wood, Liam
Published: (2023)
by: Wood, Liam
Published: (2023)
A recombinant non-toxigenic Clostridioides difficile spore vaccine directed against toxigenic C. difficile
by: Aston, Carl
Published: (2022)
by: Aston, Carl
Published: (2022)
Investigating the bile acid mediated control of Clostridioides difficile infection
by: von Emloh, Louise
Published: (2024)
by: von Emloh, Louise
Published: (2024)
Obtaining a lytic bacteriophage suitable for use in phage therapy against Clostridioides difficile infection
by: Kerr, Sarah
Published: (2023)
by: Kerr, Sarah
Published: (2023)
Spore germination and recurrence of clostridioides difficile infection
by: Finch, Lorna
Published: (2020)
by: Finch, Lorna
Published: (2020)
Transposon mutagenesis in RT 078 Clostridioides difficile
by: te Vrugt, Marcel
Published: (2023)
by: te Vrugt, Marcel
Published: (2023)
Effective fecal microbiota transplantation for recurrent Clostridioides difficile infection in humans is associated with increased signalling in bile acid-farnesoid X receptor-fibroblast growth factor pathway
by: Monaghan, Tanya M., et al.
Published: (2018)
by: Monaghan, Tanya M., et al.
Published: (2018)
Identification and characterisation of tail components modulating host range of Clostridium difficile phages
by: Steczynska, Joanna
Published: (2023)
by: Steczynska, Joanna
Published: (2023)
Formulation of minimum medium for bacteriocin production by Lactobacillus plantarum strains
by: Mazlan, Nurzafirah
Published: (2013)
by: Mazlan, Nurzafirah
Published: (2013)
Molecular characterization of bacteriocin loci in Lactobacillus plantarum I-UL4
by: Tai, Hui Fong
Published: (2013)
by: Tai, Hui Fong
Published: (2013)
Characterization of bacteriocin produced by Lactococcus lactis subsp. lactis S20 isolated from chinese Sauerkraut and its antilisterial activity In milk
by: Chin, Yih Zhet
Published: (2016)
by: Chin, Yih Zhet
Published: (2016)
Purification and Characterisation of Bacteriocin Produced by Lactococcus Lactis Subsp. Lactis RW18 Isolated From Steamed Fish (Rastrelliger Sp.)
by: Lee, Yock Ann
Published: (2002)
by: Lee, Yock Ann
Published: (2002)
Enhancement of bacteriocin production by Lactobacillus plantarum strain I-UL4 and RS5 through optimisation of cultural conditions in different sizes of stirred tank bioreactors
by: Ooi, May Foong
Published: (2017)
by: Ooi, May Foong
Published: (2017)
In silico prediction of bacteriocin gene in Weissella cibaria NM1 and in vitro enhancement of antipseudomonal activity through a combined action of antibiotics and bacteriocins from lactic acid bacteria
by: Abdul Malek, Ahmad Zuhairi
Published: (2021)
by: Abdul Malek, Ahmad Zuhairi
Published: (2021)
Both, toxin A and toxin B, are important in Clostridium difficile infection
by: Kuehne, Sarah A., et al.
Published: (2011)
by: Kuehne, Sarah A., et al.
Published: (2011)
High prevalence of subclass-specific binding and neutralizing antibodies against Clostridium difficile toxins in adult cystic fibrosis sera: possible mode of immunoprotection against symptomatic C. difficile infection
by: Monaghan, Tanya M., et al.
Published: (2017)
by: Monaghan, Tanya M., et al.
Published: (2017)
Isolation and characterisation of four novel bacteriophages infecting clinically relevant PCR ribotypes of Clostridium difficile
by: Whittle, Michaella
Published: (2018)
by: Whittle, Michaella
Published: (2018)
Exposing hidden putative lipoproteins in Clostridium difficile
by: Griffin, R., et al.
Published: (2017)
by: Griffin, R., et al.
Published: (2017)
Reduction of antimicrobial resistance through antimicrobial stewardship
by: Saxby, Claire F.
Published: (2020)
by: Saxby, Claire F.
Published: (2020)
Protective antibodies against Clostridium difficile are present in intravenous immunoglobulin and are retained in humans following its administration
by: Negm, Ola H., et al.
Published: (2017)
by: Negm, Ola H., et al.
Published: (2017)
Amino acids utilisation by Clostridium difficile strains
by: Ogbu, H.I.
Published: (2016)
by: Ogbu, H.I.
Published: (2016)
Potential Anti-Cancer Properties of Bacteriocin UL4 from Lactobacillus Plantarum in Rats Induced with Colon Cancer
by: Muhamad Zakuan, Noraina
Published: (2011)
by: Muhamad Zakuan, Noraina
Published: (2011)
Biomanufacturing of bacteriocin-like inhibitory substance producer, lactococcus lactis Gh1, with high stability in freeze-dried form
by: Jawan, Roslina
Published: (2021)
by: Jawan, Roslina
Published: (2021)
Towards development of a liposome-based vaccine to combat Clostridium difficile infection
by: Palazi, Panayiota
Published: (2021)
by: Palazi, Panayiota
Published: (2021)
Profiling humoral immune responses to Clostridium difficile-specific antigens by protein microarray analysis
by: Negm, Ola H., et al.
Published: (2015)
by: Negm, Ola H., et al.
Published: (2015)
Isolation Of Bacteriocinogenic Lactic Acid Bacteria And Purification Of Selected Bacteriocins From Traditional Fermented Foods
by: Lim, Yin Sze
Published: (2003)
by: Lim, Yin Sze
Published: (2003)
In vitro combinatory antimicrobial effect of crude bacteriocins from Pediococcus pentosaceus strains and selected antibiotics against Pseudomonas aeruginosa ATCC 10145
by: Suffian, Suffi Nurul Husna
Published: (2020)
by: Suffian, Suffi Nurul Husna
Published: (2020)
Understanding certain Clostridium difficile virulence and antibiotic resistance factors and how these relate to patient clinical outcome
by: Kinsmore, Natasha Louise
Published: (2019)
by: Kinsmore, Natasha Louise
Published: (2019)
Analysis of the spore germination mechanisms of Clostridium difficile
by: Burns, David Alexander
Published: (2011)
by: Burns, David Alexander
Published: (2011)
Novel bacteriocinogenic Lactobacillus plantarum strains and their differentiation by sequence analysis of 16S rDNA, 16S-23S and 23S-5S intergenic spacer regions and randomly amplified polymorphic DNA
by: Moghadam, Morteza Shojaei, et al.
Published: (2010)
by: Moghadam, Morteza Shojaei, et al.
Published: (2010)
The antimicrobial and bile acid mediated control of
Clostridium difficile infection
by: Dempster, Andrew William
Published: (2018)
by: Dempster, Andrew William
Published: (2018)
Mucosal cell responses to Clostridium difficile toxins
by: Mullan, Nivette K.
Published: (2011)
by: Mullan, Nivette K.
Published: (2011)
Probiotic Characteristics of Bacteriocinogenic Lactobacillus Plantarum Strains Isolated from Malaysian Foods
by: Lim, Yin Sze
Published: (2010)
by: Lim, Yin Sze
Published: (2010)
CdtR-mediated regulation of toxin production in Clostridium difficile
by: Bilverstone, Terry W.
Published: (2019)
by: Bilverstone, Terry W.
Published: (2019)
Importance of Toxin A, Toxin B, and CDT in virulence of an epidemic Clostridium difficile strain
by: Kuehne, Sarah A., et al.
Published: (2013)
by: Kuehne, Sarah A., et al.
Published: (2013)
A protein microarray assay for serological determination of antigen-specific antibody responses following Clostridium difficile infection
by: Negm, Ola H., et al.
Published: (2018)
by: Negm, Ola H., et al.
Published: (2018)
Primase is required for helicase activity and helicase alters the specificity of primase in the enteropathogen Clostridium difficile
by: van Eijk, Erika, et al.
Published: (2016)
by: van Eijk, Erika, et al.
Published: (2016)
Primase is required for helicase activity and helicase alters the specificity of primase in the enteropathogen Clostridium difficile
by: van Eijk, Erika, et al.
Published: (2016)
by: van Eijk, Erika, et al.
Published: (2016)
Similar Items
-
Identification and characterisation of potential bacteriocins with biological activity against Clostridium difficile from environmental samples
by: Kim, Sungchan
Published: (2018) -
Development of an oral vaccine against Clostridioides difficile
by: Karyal, Cansu
Published: (2021) -
Developing a protein subunit oral vaccine against Clostridioides difficile
by: Wood, Liam
Published: (2023) -
A recombinant non-toxigenic Clostridioides difficile spore vaccine directed against toxigenic C. difficile
by: Aston, Carl
Published: (2022) -
Investigating the bile acid mediated control of Clostridioides difficile infection
by: von Emloh, Louise
Published: (2024)